Efficacy and safety of once-weekly semaglutide low dose 0.5 mg vs once-weekly dulaglutide high dose 1.5 mg in type 2 diabetes: a post hoc analysis of SUSTAIN 7 Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Pratley, R. E.; Aroda, V. R.; Gondolf, T.; Hansen, T.; Lingvay, I.; Ludemann, J.; Skjoth, T. V.; Viljoen, A.

authors

Publication Date

  • September 1, 2019

webpage

published in

category

start page

  • S374

end page

  • S374

volume

  • 62